Format

Send to

Choose Destination
J Neuroimmunol. 2003 Dec;145(1-2):135-8.

C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis.

Author information

1
Department of Neurology, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita, Sapporo 060-8638, Hokkaido, Japan.

Abstract

C-C chemokine receptor 2 (CCR2) is a receptor for chemoattractant protein-1 (MCP-1) and associated with infiltrating lymphocytes in chronic active multiple sclerosis (MS) lesions. To study the role of CCR2 gene in the development of MS, we investigated the CCR2-64I polymorphism in 122 MS patients and 112 healthy controls in a Japanese population. We also analysed the influence of CCR2-64I polymorphism on the clinical course, age at disease onset, and severity. The distribution of the CCR2-64I allele was significantly different between patients and controls (p=0.0187), and the 64I/64I homozygote was significantly less common in MS than in control. Logistic analysis, adjusted for HLA-DRB1*1501-positivity, revealed negative association between the CCR2-64I and MS (p=0.0204). There were no significant associations between CCR2 polymorphism and the clinical features of MS. Our results indicate that the presence of CCR2-64I allele seems to provide protection against the development of MS.

PMID:
14644039
DOI:
10.1016/j.jneuroim.2003.09.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center